S. Pileri

2.1k total citations
23 papers, 1.2k citations indexed

About

S. Pileri is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, S. Pileri has authored 23 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pathology and Forensic Medicine, 9 papers in Genetics and 7 papers in Oncology. Recurrent topics in S. Pileri's work include Lymphoma Diagnosis and Treatment (19 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Viral-associated cancers and disorders (4 papers). S. Pileri is often cited by papers focused on Lymphoma Diagnosis and Treatment (19 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Viral-associated cancers and disorders (4 papers). S. Pileri collaborates with scholars based in Italy, United States and Germany. S. Pileri's co-authors include Brunangelo Falini, H. Stein, Elena Sabattini, Pier Luigi Zinzani, P G Isaacson, Thomas M. Grogan, Roger A. Warnke, Chris De Wolf‐Peeters, M. L. Cleary and Peter M. Banks and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and The American Journal of Surgical Pathology.

In The Last Decade

S. Pileri

23 papers receiving 1.2k citations

Peers

S. Pileri
Comparison fields: 5 of 69
  • Pathology and Forensic Medicine 929
  • Oncology 596
  • Genetics 441
  • Immunology 213
  • Pulmonary and Respiratory Medicine 174
Replace Martin Bast with:
Martin Bast United States
T. Lister United Kingdom
M. Michaela Ott Germany
P. Solal-Céligny France
Sophie Lefort France
PG Isaacson United Kingdom
Hans‐Heinrich Wacker Germany
M. Dreyling Germany
Jörg Kalla Germany
Gerardo Musuraca Italy
Martin Bast United States View profile →
Citations per field, relative to S. Pileri
S. Pileri · 1×
Citations per year, relative to S. Pileri
S. Pileri · 1×

Countries citing papers authored by S. Pileri

Since Specialization
Citations

This map shows the geographic impact of S. Pileri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Pileri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Pileri more than expected).

Fields of papers citing papers by S. Pileri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Pileri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Pileri. The network helps show where S. Pileri may publish in the future.

Co-authorship network of co-authors of S. Pileri

This figure shows the co-authorship network connecting the top 25 collaborators of S. Pileri. A scholar is included among the top collaborators of S. Pileri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Pileri. S. Pileri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 69
2 76
3 2
4 20
5 4
6 58
7 9
8 5
9 140
10
Frequent expression of the NPM-ALK chimeric fusion protein in anaplastic large-cell lymphoma, lympho-histiocytic type.
50
11 28
12
Bcl-6 protein expression in normal and neoplastic lymphoid tissues.
50
13
Nucleophosmin (NPM) gene rearrangements in Ki-1-positive lymphomas.
80
14
Bone-marrow biopsy in hairy cell leukaemia (HCL) patients. Histological and immunohistological analysis of 46 cases treated with different therapies.
12
15 374
16
In vivo targeting of Hodgkin's and Reed-Sternberg cells of Hodgkin's disease with monoclonal antibody Ber-H2. Immunoscintigrafic and immunohistological evidence.
1
17 39
18 33
19 16
20 6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026